Wiedemann R, Hepp H
Ludwig-Maximilians-Universität München, Klinikum Grosshadern, Frauenklinik.
Geburtshilfe Frauenheilkd. 1989 May;49(5):416-22. doi: 10.1055/s-2008-1036394.
The birth of the first baby following in-vitro fertilisation and embryo transfer (IVF/ET) in 1978 and the introduction of gamete intrafallopian transfer (GIFT) in 1984 have increased the treatment modalities in operative reproductive medicine. In tubal pathology, there are besides micro-surgery now so-called additive methods available for treating infertility. With regard to the indications, there has been severe confusion, and it is therefore imperative to define special indications for IVF/ET, microsurgery and GIFT. We do not consider these treatment modalities as alternative methods. Reproductive centres should offer all these treatments to guarantee an appropriate individual programme for each couple. Therefore, knowledge of pregnancy rates is a prerequisite for the doctor. The aim of this paper is, to define the optimal therapy while taking into account the individual problems of each couple.
1978年首例体外受精和胚胎移植(IVF/ET)婴儿诞生,1984年配子输卵管内移植(GIFT)的引入增加了生殖医学手术中的治疗方式。在输卵管病变方面,除了显微手术外,现在还有所谓的辅助方法可用于治疗不孕症。关于适应症,一直存在严重的混淆,因此必须明确IVF/ET、显微手术和GIFT的特殊适应症。我们不认为这些治疗方式是替代方法。生殖中心应提供所有这些治疗方法,以确保为每对夫妇制定合适的个性化方案。因此,了解妊娠率是医生的先决条件。本文的目的是在考虑每对夫妇的个体问题的同时确定最佳治疗方法。